Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

59.29 +1.95 (+3.40%)
Streaming Delayed Price Updated: 12:07 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novo Nordisk A/S Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
News headline image
Eastover Opens a Brand New $3.3 Million Novo Nordisk Position ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Novo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion ↗
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion, adding EFX, a late-stage MASH treatment candidate, to its metabolic disease portfolio. 
Via Benzinga
News headline image
Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout ↗
The deal follows Roche's plan to buy 89bio, another MASH-focused biotech company. 
Via Investor's Business Daily
Dow Futures Inch Up As Wall Street Awaits Jerome Powell’s Speech: TSLA, NVO, DAL, PEP Among Stocks To Watch ↗
Via Stocktwits
Topics Economy Stocks
News headline image
What’s Driving The Super Rally In Akero Shares On Thursday Morning? ↗
Novo Nordisk is set to acquire the firm, and Akero’s shareholders will receive $54 per share in cash at closing in addition to a contingent value right. 
Via Stocktwits
Novo Nordisk Reportedly Slashes Workforce At Its US Wegovy Manufacturing Plant ↗
Via Stocktwits
Novo Nordisk Retail Traders Stay Bullish Despite Brutal 2025 — Analysts Flag A Key Catalyst That Can Turn Things Around ↗
Via Stocktwits
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients ↗
Via Stocktwits
News headline image
Carolina Wealth Makes a Big $6 Million Bet on Novo Nordisk (NYSE: NVO) ↗
Via The Motley Fool
News headline image
Wegovy, Ozempic Maker Novo Nordisk Cuts Staff At Key US Production Sites ↗
Novo Nordisk has cut dozens of jobs at its Clayton, North Carolina site, part of a global restructuring as it faces slowing weight-loss drug sales. 
Via Benzinga
News headline image
Where Will LLY Be in 5 Years? ↗
After nearly two years of sideways price action, Eli Lilly stock could soar to new highs between now and 2030. 
Via The Motley Fool
Topics World Trade
News headline image
Skye Bioscience's Investigational Drug Disappoints As Monotherapy For Weight Loss ↗
Skye Bioscience'a trial showed nimacimab alone missed goals, while a combo with Novo Nordisk's drug delivered stronger weight loss results. 
Via Benzinga
News headline image
2 Beaten-Down Stocks Primed for a Comeback ↗
The market is sleeping on these stocks, but you don't have to. 
Via The Motley Fool
News headline image
Anthropic’s Claude AI: Seamless Integration into Everyday Life
Anthropic, a leading artificial intelligence research company, is making significant strides in embedding its powerful Claude AI into the fabric of daily applications and enterprise workflows. With a... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Novo Nordisk (NVO) Soars as HSBC Upgrades to "Buy," Citing Strategic Focus and Pipeline Strength
Copenhagen, Denmark – October 2, 2025 – Shares of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) experienced a significant surge yesterday, October 1, 2025, following a pivotal upgrade from HSBC.... 
Via MarketMinute
Topics Economy
News headline image
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
 
Via Benzinga
News headline image
Novo Nordisk (NYSE:NVO) Presents a Compelling Case for Value Investors ↗
Novo Nordisk (NVO) presents a strong value investment case with an attractive valuation, high profitability, and solid financial health. 
Via Chartmill
News headline image
Why Shares in Novo Nordisk Bumped Higher Today ↗
Pfizer's deal with the Trump administration raised hopes that the European company wouldn't be subject to 100% tariffs on certain imported drugs. 
Via The Motley Fool
Topics Government World Trade
News headline image
Q3 2025 Market Marvels: S&P 500's Standout Performers and Their Catalysts
As the third quarter of 2025 draws to a close, the financial markets are abuzz with the exceptional performances of several S&P 500 companies. While official data is still being compiled, preliminary... 
Via MarketMinute
Topics Artificial Intelligence Data Breach Earnings
News headline image
Pfizer Plummets as Key Obesity Drug Candidate Faces Major Setback, Shaking Investor Confidence
New York, NY – September 30, 2025 – Shares of pharmaceutical giant Pfizer (NYSE: PFE) experienced a dramatic decline today, making it one of the market's bottom performers, following an unexpected and... 
Via MarketMinute
Topics Intellectual Property
News headline image
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Trump's Plan To Lower U.S. Drug Prices Faces Big Test ↗
But Trump might get less than he bargained for as drugmakers focus on prices abroad, rather than stateside efforts. 
Via Investor's Business Daily
Topics Government
News headline image
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S (NVO) Shareholders
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S (NVO) Shareholders
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Why Is Novo Nordisk Stock Down in 2025, and Is It a Buying Opportunity? ↗
Political pressure on Big Pharma is one reason why the industry is underperforming in 2025. 
Via The Motley Fool
News headline image
These 2 Top Dividend Stocks Are Finally Rebounding, and There Might Be More Upside Ahead ↗
It's hard to keep these longtime winners down for too long. 
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
News headline image
Why Novo Nordisk Stock Slumped on Monday ↗
A pundit tracking the company cited several reasons why investors should sell out of it. 
Via The Motley Fool
Topics World Trade
News headline image
Deadline Soon: Novo Nordisk A/S (NVO) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
NOVO URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30th
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Contact Levi &amp; Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)
Via TheNewswire.com
Topics Fraud Lawsuit
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.